Medexus Pharma said it expects to launch Grafapex in the first half of this year. The US Food and Drug Administration (FDA) has approved Grafapex (treosulfan) for use in combination with fludarabine ...

I call it cancer — the cancer caused by the Biden administration,” Trump told reporters.

Policies that improve payer coverage, streamline authorization processes, and reduce cost-sharing burdens for medical equipment are urgently needed,” according to researchers.

Adding intraperitoneal paclitaxel to intravenous paclitaxel and oral S-1 improved survival in patients with gastric cancer and peritoneal metastasis.

President Donald Trump’s early actions on health care signal his likely intention to wipe away some Biden-era programs to lower drug costs and expand coverage under public insurance programs.

Medicare plans to negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities.

President Donald Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid.

Treating initially unresectable gastric or GEJ cancer with camrelizumab plus nab-POF led to an R0 resection rate of 75% in a phase 2 trial.

Apologies can help improve the quality of the treatment relationship by restoring trust and sharing power with the patient.

Adding evorpacept to treatment with trastuzumab, ramucirumab, and paclitaxel may improve outcomes in HER2-positive gastric/GEJ cancer.

Use of long-acting, reversible contraceptives is associated with an increased risk of certain cancers, a study suggests.

Perioperative chemotherapy improved outcomes when compared to preoperative chemoradiotherapy in a phase 3 trial of patients with resectable esophageal cancer. Results from this tr ...